openPR Logo
Press release

Ensuring Research Precision with Balsalazide Impurity Standards from Aquigen Bio

07-07-2025 11:33 AM CET | Chemicals & Materials

Press release from: Aquigen Bio Sciences

Ensuring Research Precision with Balsalazide Impurity

Ensuring Research Precision with Balsalazide Impurity Standards from Aquigen Bio
Aquigen Bio, a trusted global partner in pharmaceutical research and chemical reference materials, proudly introduces its high-quality Balsalazide Impurity Standards, designed to meet the stringent needs of the pharmaceutical and research industries.

Balsalazide disodium is a well-established anti-inflammatory drug used in the treatment of ulcerative colitis. As regulatory expectations grow tighter across global markets, the demand for reliable impurity standards-especially for drugs like Balsalazide-has never been greater. Aquigen Bio delivers on this front with unmatched purity, compliance, and customer-focused support.

A Closer Look at Aquigen's Balsalazide Impurity Portfolio
To support robust research, quality control, and regulatory compliance, Aquigen Bio offers a diverse set of Balsalazide impurity reference standards including:

Balsalazide USP Impurity 2
https://aquigenbio.com/product/balsalazide-usp-impurity-2/
This impurity standard is critical for stability testing and impurity profiling during the drug development lifecycle. Its superior analytical data package supports traceability and regulatory filing needs.

Balsalazide USP Impurity 1
https://aquigenbio.com/product/balsalazide-usp-impurity-1/
Ideal for use in method validation, impurity quantification, and structural elucidation studies. Aquigen ensures its synthesis under strict cGMP guidelines, aligning with global pharmacopoeial standards.

Balsalazide USP Impurity 4
https://aquigenbio.com/product/balsalazide-usp-impurity-4/
Developed with accuracy and reproducibility in mind, this impurity plays a key role in analytical performance and toxicological risk assessments.

Why Choose Aquigen Bio?
Aquigen Bio stands out for its unwavering commitment to quality, scientific integrity, and customer-centric innovation. Here's why researchers and pharmaceutical manufacturers trust Aquigen for impurity standards:
Regulatory Compliance: All Balsalazide impurity standards are synthesized under ICH and GMP conditions and come with comprehensive COAs and NMR, LC-MS, and HPLC data.

Quick Turnaround: With ready-to-dispatch inventory, Aquigen ensures fast global shipping.

Custom Synthesis Capabilities: Beyond listed impurities, Aquigen also offers custom impurity synthesis and stable isotope-labeled compounds.

Explore the complete Balsalazide Impurity Standards category to support your next research breakthrough. https://aquigenbio.com/products/impurity-standards/balsalazide/

About Aquigen Bio
Aquigen Bio is a leading provider of certified reference standards, impurity profiling compounds, and research chemicals to pharma, biotech, and academic institutions worldwide. With a dedication to excellence and a focus on regulatory readiness, Aquigen empowers scientists to innovate with confidence.

Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Visit: www.aquigenbio.com

Aquigen Bio Sciences stands as India's premier resource for high-quality N-Nitroso impurity standards, impelling advancements in pharmaceutical research and manufacturing. Specializing in providing precise impurity standards - including degradation impurities, process impurities, and deuterated isotopes - Aquigen Bio Sciences empowers the industry to comply with the most rigorous global regulations. The contract research organization's commitment to precision and reliability makes it the trusted partner for addressing complex issues like N-Nitroso impurities in pharmaceuticals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ensuring Research Precision with Balsalazide Impurity Standards from Aquigen Bio here

News-ID: 4092559 • Views:

More Releases from Aquigen Bio Sciences

Estradiol Valerate EP Impurity A - Premium Reference Standard for Analytical Development, Quality Control, and Regulatory Compliance in Pharmaceutical Research
Estradiol Valerate EP Impurity A - Premium Reference Standard for Analytical Dev …
Estradiol Valerate EP Impurity A is a high-quality reference standard designed to meet the stringent requirements of pharmaceutical research, method validation, and quality control processes. Explore Estradiol Valerate EP Impurity A : https://aquigenbio.com/product/estradiol-valerate-ep-impurity-a/ Manufactured and characterized with precision, this impurity standard supports laboratories and manufacturers in achieving consistent, reliable, and reproducible results in critical analytical workflows. With its exceptional purity and accurate characterization, Estradiol Valerate EP Impurity A plays a vital role
High-Purity N-Nitroso Betahistine D3 for Precise Pharmaceutical Analysis | Deuterated Nitrosamine Impurity Standard for Method Development, Validation, Quality Control, and Regulatory Submissions in Betahistine Impurity Profiling and Research
High-Purity N-Nitroso Betahistine D3 for Precise Pharmaceutical Analysis | Deute …
Product Overview N-Nitroso Betahistine D3 is a premium deuterated nitrosamine impurity standard, specifically developed for precise analytical testing in pharmaceutical laboratories. This reference standard is widely used for analytical method development, validation, and quality control processes to meet stringent regulatory guidelines. With exceptional purity, complete documentation, and reliable traceability, it is ideal for research, development, and compliance applications. https://aquigenbio.com/product/n-nitroso-betahistine-d3/ Key Features and Benefits Deuterated Design for Precision: The incorporation of deuterium improves mass spectrometric
Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impurity Standards
Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impur …
Aquigen Bio, a trusted supplier of pharmaceutical reference standards, today announced the expansion of its Icatibant Impurity Standards portfolio, designed to support drug developers, analytical laboratories, and research organizations with reliable materials for impurity profiling and quality control. Icatibant, a selective bradykinin B2 receptor antagonist, is widely used in the treatment of hereditary angioedema (HAE). Given its peptide-based structure, Icatibant is prone to the formation of impurities during synthesis and storage.
Elevating Analytical Precision with Harmine Impurity Standards
Elevating Analytical Precision with Harmine Impurity Standards
In the realm of pharmaceutical research, controlling the purity of compounds is pivotal. When evaluating psychoactive alkaloids such as harmine-a β-carboline alkaloid known for its reversible monoamine oxidase A inhibition and emerging therapeutic potential-accuracy is non-negotiable. This is where Aquigen Bio Sciences brings its edge: supplying high-grade impurity standards to underpin analytical consistency and regulatory compliance. Why Harmine Impurity Standards Matter https://aquigenbio.com/products/impurity-standards/harmine/ Harmine occurs naturally in Peganum harmala and Banisteriopsis caapi, and has

All 5 Releases


More Releases for Balsalazide

Ulcerative Colitis Market Is Booming So Rapidly 2025-2032 -Mesalamine (Asacol an …
Latest Qualitative Research Report on the Ulcerative Colitis Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research explores into the evolving Market's dynamics, value chain analysis, prominent investment areas, competitive landscape, drivers and constraints, regional outlook, and key market segments. It's also provides the industry overview with growth analysis and historical
Global Balsalazide Market Imapct of AI and Automation
Balsalazide Market Impact of AI and Automation The global Balsalazide market was valued at approximately USD 240 million in 2022. It is projected to grow at a compound annual growth rate (CAGR) of around 5.5% from 2022 to 2030. This growth is attributed to the rising prevalence of inflammatory bowel diseases (IBD) and increasing awareness about the benefits of Balsalazide in managing these conditions. Additionally, advancements in drug formulation and increased
Global Balsalazide Disodium Market Imapct of AI and Automation
Balsalazide Disodium Market Impact of AI and Automation The global Balsalazide Disodium market was valued at approximately USD 225 million in 2022 and is projected to reach around USD 285 million by 2027. The market is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 5.2% during this period. This growth trajectory is driven by the increasing prevalence of inflammatory bowel disease (IBD) and the rising demand for effective
Balsalazide Market 2024 Global Share, Key Country Analysis and Forecasts
The Balsalazide Market delivers a comprehensive study of the market, including its dynamics, structure, characteristics, Key players, growth and demand drivers, etc. As a Complete Analysis report, it covers all details inside analysis and outlook according to The Insight Partners. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00021881/?utm_source=OpenPR&utm_medium=10807 Key Players Analysis: PD-Rx Pharmaceuticals, Inc. Oceanside Pharmaceuticals AvKARE, LLC. Apotex Corp. American Health Packaging Golden State Medical Supply, Inc.
Balsalazide Market Analysis by Advanced Technology, Trends, Forecasts to 2028 & …
Balsalazide market report always keeps a goal to provide thorough understanding of the entire market. In order to secure the funds of the industries, it aims at providing some independent facts. It further goes on delivering data about market share, market tactics, growth factors and COVID-19 pandemic effects on both small scale and large-scale business sectors. Key success factors, key success details, distribution channels and industry pricing structure are some
Global Balsalazide Market Overview by Recent Opportunities, Growth Size, Regiona …
The global balsalazide market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Balsalazide is an anti-inflammatory drug. It is converted in the body to mesalamine and works by reducing the prevalence of bowel inflammation such as Crohn's disease and ulcerative colitis, rectal bleeding, and stomach pain. According to the data published by National Center for Biotechnology Information in 2021, ulcerative colitis is estimated to have